Kensuke Nakamura1, Kentaro Ogura2,3, Hidehiko Nakano4, Hiromu Naraba4, Yuji Takahashi4, Tomohiro Sonoo4,3, Hideki Hashimoto4, Naoto Morimura5. 1. Department of Emergency and Critical Care MHiedicine, Hitachi General Hospital, 2-1-1, Jonan-cho, Hitachi, Ibaraki, 317-0077, Japan. mamashockpapashock@yahoo.co.jp. 2. Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo, 113-8655, Japan. 3. TXP Medical Co. Ltd, 3-13 Nihonbashiyokoyamacho, Chuo-ku, Tokyo, 103-0003, Japan. 4. Department of Emergency and Critical Care MHiedicine, Hitachi General Hospital, 2-1-1, Jonan-cho, Hitachi, Ibaraki, 317-0077, Japan. 5. Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo, Tokyo, 113-8655, Japan.
Abstract
PURPOSE: Among patients surviving treatment in intensive care units (ICU), some cases exist for which inflammation persisted with prolonged hospital stays, referred as persistent inflammatory, immunosuppressed, catabolic syndrome (PIICS). C reactive protein (CRP) is regarded as the most important marker for PIICS. Nevertheless, the applicable cut-off of CRP for PIICS has never been described in the literature. METHODS: Data of patients admitted to the ICU/Emergency ward from May 2015 through June 2019 were analyzed retrospectively. Using K-means clustering, a 14-day CRP transition dataset was analyzed and categorized finally into 7 classes: 4 PIICS classes and 3 non-PIICS classes. Outcomes and the other PIICS characteristics were evaluated. RESULTS: From all 5513 admitted patients, this study examined data of 539 patients who had been admitted for more than 14 days, and for whom 14 day CRP transition analysis could be performed. By the CRP transitions of 7 categorized classes, the CRP cut-off for PIICS was regarded as 3.0 mg/dl on day 14. The Barthel Index at discharge, albumin, and total lymphocyte counts on day 14 were significantly lower in PIICS classes than those of non-PIICS classes. Creatinine kinase, antithrombin activity and thrombomodulin on admission were regarded as independent risk factors for PIICS. CONCLUSIONS: Among patients with prolonged hospital stay, the PIICS population had elevated CRP, but lower Barthel Index, albumin, and total lymphocyte counts. The criterion of day 14 CRP for PIICS should be 3.0 mg/dl.
PURPOSE: Among patients surviving treatment in intensive care units (ICU), some cases exist for which inflammation persisted with prolonged hospital stays, referred as persistent inflammatory, immunosuppressed, catabolic syndrome (PIICS). C reactive protein (CRP) is regarded as the most important marker for PIICS. Nevertheless, the applicable cut-off of CRP for PIICS has never been described in the literature. METHODS: Data of patients admitted to the ICU/Emergency ward from May 2015 through June 2019 were analyzed retrospectively. Using K-means clustering, a 14-day CRP transition dataset was analyzed and categorized finally into 7 classes: 4 PIICS classes and 3 non-PIICS classes. Outcomes and the other PIICS characteristics were evaluated. RESULTS: From all 5513 admitted patients, this study examined data of 539 patients who had been admitted for more than 14 days, and for whom 14 day CRP transition analysis could be performed. By the CRP transitions of 7 categorized classes, the CRP cut-off for PIICS was regarded as 3.0 mg/dl on day 14. The Barthel Index at discharge, albumin, and total lymphocyte counts on day 14 were significantly lower in PIICS classes than those of non-PIICS classes. Creatinine kinase, antithrombin activity and thrombomodulin on admission were regarded as independent risk factors for PIICS. CONCLUSIONS: Among patients with prolonged hospital stay, the PIICS population had elevated CRP, but lower Barthel Index, albumin, and total lymphocyte counts. The criterion of day 14 CRP for PIICS should be 3.0 mg/dl.
Authors: Dale M Needham; Judy Davidson; Henry Cohen; Ramona O Hopkins; Craig Weinert; Hannah Wunsch; Christine Zawistowski; Anita Bemis-Dougherty; Susan C Berney; O Joseph Bienvenu; Susan L Brady; Martin B Brodsky; Linda Denehy; Doug Elliott; Carl Flatley; Andrea L Harabin; Christina Jones; Deborah Louis; Wendy Meltzer; Sean R Muldoon; Jeffrey B Palmer; Christiane Perme; Marla Robinson; David M Schmidt; Elizabeth Scruth; Gayle R Spill; C Porter Storey; Marta Render; John Votto; Maurene A Harvey Journal: Crit Care Med Date: 2012-02 Impact factor: 7.598
Authors: Julie A Stortz; Juan C Mira; Steven L Raymond; Tyler J Loftus; Tezcan Ozrazgat-Baslanti; Zhongkai Wang; Gabriela L Ghita; Christiaan Leeuwenburgh; Mark S Segal; Azra Bihorac; Babette A Brumback; Alicia M Mohr; Philip A Efron; Lyle L Moldawer; Frederick A Moore; Scott C Brakenridge Journal: J Trauma Acute Care Surg Date: 2018-02 Impact factor: 3.313
Authors: Jeremy M Kahn; Tri Le; Derek C Angus; Christopher E Cox; Catherine L Hough; Douglas B White; Sachin Yende; Shannon S Carson Journal: Crit Care Med Date: 2015-02 Impact factor: 7.598
Authors: Jesús Beltrán-García; Rebeca Osca-Verdegal; Beatriz Jávega; Guadalupe Herrera; José-Enrique O'Connor; Eva García-López; Germán Casabó-Vallés; María Rodriguez-Gimillo; José Ferreres; Nieves Carbonell; Federico V Pallardó; José Luis García-Giménez Journal: Biomedicines Date: 2022-02-23